Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Rocket Pharmaceuticals Inc fell by 84.58m. Cash Flow from Financing totalled 208.40m or -- of revenues. In addition the company used 194.92m for operations while cash used for investing totalled 98.07m.
Cash flow per share | -2.70 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.23 |
---|---|
Tangible book value per share | 3.52 |
More ▼
Balance sheet in USDView more
Current ratio | 7.79 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0551 |
---|---|
Total debt/total capital | 0.0522 |
More ▼